MILRINONE LACTATE INJECTION USP

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: ffc7ad6ee90a8a04
Drug Approval Canada Name: MILRINONE LACTATE INJECTION USP
Product Name: MILRINONE LACTATE INJECTION USP
Status: Marketed
Status Date: 2023-05-31
Original Market Date: 2023-05-31
Din: 02521407
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 24:04.08
Atc Original: C01CE02 MILRINONE
Atc Name: c 01 ce 02
Aig Number: 0131285001
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

MILRINONE (MILRINONE LACTATE)

1 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ffc7ad6ee90a8a04

Type

Standard